NVO Novo Nordisk A/S Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

NVO [NYSE]

Novo Nordisk A/S

Healthcare | Drug Manufacturers - General | Denmark

statements

Index	-	P/E	25.61	EPS (ttm)	2.77	Insider Own	26.40%	Shs Outstand	2.34B	Perf Week	-1.23%
Market Cap	127.58B	Forward P/E	22.94	EPS next Y	3.09	Insider Trans	0.00%	Shs Float	1.13B	Perf Month	2.59%
Income	6.52B	PEG	2.85	EPS next Q	0.71	Inst Own	8.30%	Short Float	0.37%	Perf Quarter	6.67%
Sales	19.91B	P/S	6.41	EPS this Y	2.80%	Inst Trans	-0.03%	Short Ratio	4.43	Perf Half Y	10.74%
Book/sh	4.04	P/B	17.54	EPS next Y	8.69%	ROA	32.30%	Target Price	72.35	Perf Year	32.95%
Cash/sh	2.17	P/C	32.61	EPS next 5Y	9.00%	ROE	73.70%	52W Range	49.24 - 73.81	Perf YTD	22.41%
Dividend	1.04	P/FCF	27.56	EPS past 5Y	10.20%	ROI	69.10%	52W High	-4.61%	Beta	0.41
Dividend %	1.47%	Quick Ratio	0.80	Sales past 5Y	6.60%	Gross Margin	83.70%	52W Low	42.99%	ATR	1.27
Employees	43526	Current Ratio	1.10	Sales Q/Q	-0.10%	Oper. Margin	43.40%	RSI (14)	51.90	Volatility	1.35% 1.41%
Optionable	Yes	Debt/Eq	0.07	EPS Q/Q	12.90%	Profit Margin	32.70%	Rel Volume	1.01	Prev Close	70.85
Shortable	Yes	LT Debt/Eq	0.05	Earnings	Aug 06 BMO	Payout	294.40%	Avg Volume	941.21K	Price	70.41
Recom	3.00	SMA20	-0.01%	SMA50	3.14%	SMA200	9.92%	Volume	343,234	Change	-0.62%

Sep-29-20

Initiated

Berenberg

Hold

Jul-06-20

Downgrade

BofA Securities

Buy → Neutral

May-11-20

Downgrade

UBS

Buy → Neutral

May-04-20

Initiated

Cowen

Market Perform

$72

Mar-16-20

Upgrade

BofA/Merrill

Neutral → Buy

Jan-03-20

Downgrade

Guggenheim

Buy → Neutral

Nov-18-19

Upgrade

Barclays

Equal Weight → Overweight

Sep-17-19

Upgrade

Citigroup

Neutral → Buy

Aug-30-19

Downgrade

Jefferies

Hold → Underperform

Jun-20-19

Downgrade

Deutsche Bank

Buy → Hold

Jun-11-19

Upgrade

Barclays

Underweight → Equal Weight

Apr-29-19

Upgrade

Credit Suisse

Neutral → Outperform

Jan-29-19

Initiated

Exane BNP Paribas

Outperform

Dec-11-18

Resumed

Jefferies

Hold

Oct-09-18

Initiated

Guggenheim

Buy

Dec-29-17

Upgrade

JP Morgan

Underweight → Neutral

Dec-06-17

Upgrade

BofA/Merrill

Neutral → Buy

Dec-01-17

Upgrade

Morgan Stanley

Equal-Weight → Overweight

Sep-25-17

Downgrade

Exane BNP Paribas

Outperform → Neutral

Sep-06-17

Upgrade

BofA/Merrill

Underperform → Neutral

Oct-19-20 06:50PM	4 Health Care Companies With Strong Business Quality GuruFocus.com
11:40AM	SNY or NVO: Which Is the Better Value Stock Right Now? Zacks
07:24AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Oct-13-20 03:31PM	Q3 Earnings Scorecard and Top Research Reports for Apple, PepsiCo & McDonald's Zacks
Oct-12-20 04:14AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Oct-11-20 01:52PM	IPO Outlook: Solar Power Company Array Technologies, Chinese Retailer Miniso Lead Possible 9 IPO Week Benzinga
Oct-09-20 01:41PM	Pharma Stock Roundup: LLY, AZN, PFE, GSK Progress on Coronavirus Programs Zacks
12:30PM	Novo Nordisk Raises Sales & Operating Profit Outlook for 2020 Zacks
03:04AM	European stocks rise on upbeat forecasts from Pandora, Novo Nordisk Reuters
Oct-08-20 12:40PM	Novo Nordisk raises sales and operating profit outlook for 2020 GlobeNewswire
Oct-05-20 08:35AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Sep-29-20 06:47PM	5 Health Care Stocks Outperforming the S&P 500 GuruFocus.com
08:44AM	Novo Nordisk A/S (NVO): Hedge Funds In Wait-and-See Mode Insider Monkey
Sep-28-20 08:20AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
03:02AM	Stocks Jump, Trump's Tax and Uber Licenses: What's up in Markets on Monday Investing.com
Sep-24-20 04:30AM	Worlds largest study of cardiovascular disease in type 2 diabetes shows need for improved knowledge and disease management GlobeNewswire
Sep-22-20 08:46AM	Switching to investigational once-weekly insulin icodec from other basal insulins demonstrated to be efficacious and well-tolerated for people with type 2 diabetes in phase 2 trial GlobeNewswire
Sep-21-20 02:03PM	The Zacks Analyst Blog Highlights: JPM, PYPL, NVO, RHHBY and TM Zacks
10:13AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Sep-18-20 03:14PM	Top Analyst Reports for JPMorgan, PayPal & Novo Nordisk Zacks
11:40AM	SNY vs. NVO: Which Stock Should Value Investors Buy Now? Zacks
Sep-16-20 10:19PM	15 States With The Highest Diabetes Rates In U.S. Insider Monkey
Sep-14-20 04:59AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Sep-07-20 08:02AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Aug-31-20 09:03AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Aug-26-20 03:38PM	Why Altimmune Stock Tanked Today Motley Fool
Aug-24-20 09:24AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Aug-17-20 08:59AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Aug-14-20 09:18AM	Novo Nordisk (NVO) Resumes Phase III Hemophilia Studies Zacks
Aug-13-20 05:11AM	3 Top Diabetes Stocks to Buy in August Motley Fool
Aug-11-20 10:42AM	Novo Nordisk A/S -- Moody's announces completion of a periodic review of ratings of Novo Nordisk A/S Moody's
Aug-07-20 12:24PM	5 Health Care Companies Outperforming the Market GuruFocus.com
11:30AM	Pharma Stock Roundup: ABBV, MRK Q2 Earnings & Coronavirus Updates in Focus Zacks
Aug-06-20 11:34AM	Novo Nordisk's (NVO) Q2 Earnings Beat Estimates, Sales Miss Zacks
01:53AM	Novo Nordisk tweaks outlook higher after pandemic sales hit Reuters
01:43AM	Novo Nordisk beats profit estimates, lifts outlook slightly Reuters
01:30AM	Novo Nordisk's operating profit increased by 9% in Danish kroner and by 8% at constant exchange rates (CER) in the first six months of 2020 GlobeNewswire
Aug-05-20 07:05AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Jul-30-20 07:32PM	10 Biggest Biotechnology Companies Investopedia
Jul-28-20 05:35PM	Novo, Roche Scored Highest Returns on Invested Capital GuruFocus.com
Jul-20-20 05:49AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Jul-17-20 07:13PM	Did Hedge Funds Make The Right Call On Novo Nordisk A/S (NVO)? Insider Monkey
Jul-16-20 09:28AM	How This Pioneer ESG Fund Still Outperforms 80% of Its Peers Barrons.com
Jul-13-20 10:27AM	Novo Nordisk's Shares Rise on New Approvals, Strong Portfolio Zacks
06:02AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Jul-09-20 03:57PM	Biomarin's Hemophilia A Drug Among 5 Up for FDA Approval Soon GuruFocus.com
Jul-07-20 06:48PM	5 Greenblatt Magic Formula Biotech Stocks to Weather the Summer Coronavirus Storm GuruFocus.com
Jul-06-20 04:03PM	Abbott Deal, UnitedHealth Coverage Push Up Tandem Shares GuruFocus.com
Jun-30-20 12:46PM	12 European Stocks for the Second Half of 2020 Barrons.com
Jun-22-20 09:39AM	Novo Nordisk Completes Two Studies on Obesity Candidate Zacks
Jun-19-20 12:49PM	Is Novo Nordisk (NVO) a Smart Long-term Buy? Insider Monkey
Jun-17-20 01:06PM	Before You Buy Novo Nordisk (NVO) Stock, Read This Insider Monkey
Jun-15-20 01:46PM	Here is What Hedge Funds Think About Novo Nordisk A/S (NVO) Insider Monkey
Jun-12-20 09:48AM	Pharma Stock Roundup: Coronavirus Updates From ABBV, LLY, JNJ, FDA Approvals Zacks
07:30AM	The Daily Biotech Pulse: FDA Nod For Viela, 3 IPOs And Hematology Congress Presentations Benzinga
Jun-11-20 10:15PM	Novo Nordisk to Acquire Corvidia Therapeutics for $725M Cash Zacks
10:29AM	Novo Nordisk expands into cardiovascular disease with $725 million deal Reuters
Jun-01-20 09:53AM	The Zacks Analyst Blog Highlights: Novo Nordisk, International Business Machines, Honeywell International, Amgen and S&P Global Zacks
May-29-20 12:39PM	Top Stock Reports for Novo Nordisk, IBM & Honeywell Zacks
May-27-20 08:13AM	White House announces plan for Medicare enrollees to get insulin for $35 a month MarketWatch
May-08-20 11:04AM	Pharma Stock Roundup: Q1 Earnings of BMY, NVO, Coronavirus Update From PFE, RHHBY Zacks
07:17AM	Novo Nordisk A/S (CPH:NOVO B) Just Beat Earnings: Here's What Analysts Think Will Happen Next Simply Wall St.
May-07-20 11:18AM	Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates Zacks
May-06-20 09:00PM	Novo Nordisk A/S (NVO) Q1 2020 Earnings Call Transcript Motley Fool
03:03AM	European shares flat as mixed earnings, U.S.-China tensions weigh Reuters
Apr-30-20 11:40AM	SNY vs. NVO: Which Stock Is the Better Value Option? Zacks
Apr-29-20 09:27AM	The Zacks Analyst Blog Highlights: Visa, Novo Nordisk, American Tower, Caterpillar and 3M Zacks
Apr-28-20 12:33PM	Tracking Q2 and Full-Year 2020 Earnings Estimates Zacks
Apr-26-20 03:11AM	Novo Nordisk (CPH:NOVO B) Could Easily Take On More Debt Simply Wall St.
Apr-16-20 06:50PM	5 Pharmaceutical Companies to Consider as Coronavirus Vaccine Race Heats Up GuruFocus.com
Apr-14-20 02:43PM	Novo Nordisk offers free 90-day insulin supply to people experiencing financial hardship due to COVID-19 PR Newswire
09:42AM	The Zacks Analyst Blog Highlights: Alibaba, Pfizer, S&P Global, Novo Nordisk and Duke Energy Zacks
Apr-09-20 09:03AM	Europe's coronavirus export bans raise concern over insulin supplies Reuters
Apr-07-20 06:33AM	Eli Lilly lowers insulin costs as coronavirus crisis deepens Reuters
Apr-06-20 06:26PM	Alnylam, Dicerna Join Forces to Take on Arrowhead GuruFocus.com
11:25AM	Novo Nordisk's Rybelsus Gets EU Nod for Type II Diabetes Zacks
Apr-05-20 09:14PM	Highlights From Fundsmith Equity Fund s 2020 Investor Letter Insider Monkey
Apr-02-20 01:20PM	Coronavirus (COVID-19) resources available from Novo Nordisk in the US PR Newswire
Apr-01-20 11:40AM	NVS vs. NVO: Which Stock Should Value Investors Buy Now? Zacks
Mar-31-20 12:43PM	The Zacks Analyst Blog Highlights: Alphabet, Procter & Gamble, Philip Morris, Novo Nordisk and Tesla Zacks
Mar-23-20 09:07AM	The Zacks Analyst Blog Highlights: Microsoft, salesforce.com, Novo Nordisk, American Express and Fiserv Zacks
06:23AM	Novo Nordisk A/S (CPH:NOVO B) Pays A ø5.35 Dividend In Just 3 Days Simply Wall St.
Mar-20-20 12:23PM	Top Analyst Reports for Microsoft, salesforce.com & Novo Nordisk Zacks
10:52AM	Pharma Stock Roundup: SNY, RHHBY, PFE's Coronavirus Product Development & Other Updates Zacks
Mar-19-20 06:51PM	5 Dividend Growth Stocks Hedge Fund Gurus Own GuruFocus.com
Mar-12-20 08:41PM	Were Hedge Funds Right About Buying Novo Nordisk A/S (NVO)? Insider Monkey -7.72%
Mar-11-20 08:45AM	US govt aims at high insulin prices with plan for $35 copay in Medicare Reuters -5.16%
Mar-10-20 05:26AM	If You Had Bought Novo Nordisk (CPH:NOVO B) Shares Three Years Ago You'd Have Made 68% Simply Wall St.
12:30AM	More choice means higher prices for American diabetics Financial Times
12:30AM	Poor countries struggle to get the insulin they need Financial Times
Mar-04-20 12:51PM	A Trio of Stocks Growing Earnings Fast GuruFocus.com +5.33%
Feb-20-20 05:10PM	Oscar Health unveils program for lower drug prices, including insulin Yahoo Finance
Feb-13-20 11:40AM	SNY vs. NVO: Which Stock Should Value Investors Buy Now? Zacks
Feb-12-20 10:29AM	Cinven hires IPO adviser for German lab group Synlab -sources Reuters
Feb-09-20 02:21AM	Don't Sell Novo Nordisk A/S (CPH:NOVO B) Before You Read This Simply Wall St.
01:24AM	Novo Nordisk A/S Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock? Simply Wall St.
Feb-07-20 10:24AM	Pharma Stock Roundup: BMY, GSK, SNY Q4 Results, MRK Earnings & Split Zacks
Feb-06-20 12:29PM	Coronavirus update: 565 deaths, more than 28,000 cases worldwide, Yum China reports significant interruption MarketWatch
Feb-05-20 04:11PM	13 Key NASH Drug Candidates To Watch For In A Potential $30-Billion Market Benzinga
11:11AM	Novo Nordisk (NVO) Q4 Earnings Match Estimates, Revenues Beat Zacks

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharmaceuticals. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company has a strategic alliance with Evotec AG to discover and develop small molecule therapies to treat patients suffering from diabetes, obesity, and co-morbidities, as well as has a research collaboration with Kallyope Inc. It also has collaboration agreements with Lund University to develop stem cell-derived treatment for Parkinson's diseases; Staten Biotechnology B.V. to develop novel therapeutics for the treatment of dyslipidaemia; Medtronic plc to develop integrated digital solutions for people with diabetes; and bluebird bio, Inc. to develop in vivo genome editing treatments for genetic diseases. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience